Response and Overall Survival for Yttrium-90 Radioembolization of Hepatic Sarcoma: A Multicenter Retrospective Study.

[1]  N. Araki,et al.  The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study , 2016, Cancer.

[2]  R. Awad,et al.  Radiation recall pneumonitis induced by erlotinib after palliative thoracic radiotherapy for lung cancer: Case report and literature review , 2016, Asia-Pacific journal of clinical oncology.

[3]  J. Geschwind,et al.  Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver - the use of imaging biomarkers as predictors of patient survival. , 2015, European journal of radiology.

[4]  Chi-Chih Wang,et al.  Surgical experience of adult primary hepatic sarcomas , 2015, World Journal of Surgical Oncology.

[5]  S. Schoenberg,et al.  Radioembolization in patients with progressive gastrointestinal stromal tumor liver metastases undergoing treatment with tyrosine kinase inhibitors. , 2015, Journal of vascular and interventional radiology : JVIR.

[6]  J. Mondschein,et al.  Risk of Liver Abscess Formation in Patients with Prior Biliary Intervention Following Yttrium-90 Radioembolization , 2015, CardioVascular and Interventional Radiology.

[7]  J. Blay,et al.  Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. , 2014, The Lancet. Oncology.

[8]  Clara C. Chen,et al.  Epidemiology, Treatment Patterns, and Outcomes of Metastatic Soft Tissue Sarcoma in a Community-Based Oncology Network , 2014, Sarcoma.

[9]  M. Heckman,et al.  Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patients. , 2013, Brachytherapy.

[10]  Luiz Gustavo Orlandi de Souza,et al.  Chemoembolisation combined with percutaneous radiofrequency ablation in the treatment of primary angiosarcoma of the liver , 2013, BMJ Case Reports.

[11]  J. Blay,et al.  Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial , 2012, The Lancet.

[12]  E. Ozkan,et al.  Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors , 2011, World journal of surgical oncology.

[13]  A. Benson,et al.  Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times. , 2011, Gastroenterology.

[14]  B. Sangro,et al.  General Selection Criteria of Patients for Radioembolization of Liver Tumors: An International Working Group Report , 2011, American journal of clinical oncology.

[15]  R. Murthy,et al.  [90Y]yttrium microspheres radioembolotherapy in desmoplastic small round cell tumor hepatic metastases. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  J. Blay,et al.  Trends in survival for patients with metastatic soft‐tissue sarcoma , 2011, Cancer.

[17]  K. Sung,et al.  Primary hepatic angiosarcoma: imaging findings and palliative treatment with transcatheter arterial chemoembolization or embolization. , 2009, Clinical radiology.

[18]  A. Benson,et al.  Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival. , 2008, Radiology.

[19]  M. Guiney,et al.  Hepatic Angiosarcoma Presenting as an Acute Intraabdominal Hemorrhage Treated with Transarterial Chemoembolization , 2007, Sarcoma.

[20]  M. D'Angelica,et al.  Management of primary liver sarcomas , 2007, Cancer.

[21]  K. Brown,et al.  Treatment of metastatic sarcoma to the liver with bland embolization , 2006, Cancer.

[22]  A. D. Van den Abbeele,et al.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. , 2002, The New England journal of medicine.

[23]  F. Collin,et al.  Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas , 2001, Cancer.

[24]  R. Shlansky-Goldberg,et al.  Sarcomas metastatic to the liver: response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization. , 2001, Journal of vascular and interventional radiology : JVIR.

[25]  M. van Glabbeke,et al.  Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.